Prosus H1 Profit Down, Revenues Rise; Closes Acquisition Of Remaining 33.3% Stake In IFood

Prosus N.V. (PROSY, PROSF), a Dutch technology investment group, reported Wednesday that its first-half profit attributable to equity holders of the group declined to $2.54 billion from last year's $15.89 billion.

Earnings per ordinary share were 179 US cents, down from 1002 US cents a year ago. Earnings per ordinary share from continuing operations were 165 US cents, compared to 996 US cents last year.

Headline earnings per ordinary share were 11 US cents, compared to 144 US cents a year ago.

On a continuing operations basis, headline loss per ordinary share was 3 US cents, compared to profit of 138 US cents a year earlier.

Group trading profit declined 49 percent to $1.4 billion, mainly reflecting Tencent's 26 percent lower contribution to the group's trading profit and losses in consolidated ecommerce business.

Group revenue, measured on an economic-interest basis, grew 1 percent to $16.5 billion, driven mainly by a 35 percent increase in Ecommerce revenues.

On a consolidated basis, total revenue increased 18 percent to $3.24 billion from $2.75 billion in the prior period.

Separately, Prosus said it has closed the acquisition of remaining 33.3 percent stake in iFood Holdings B.V. and IF-JE Holdings B.V. from minority shareholder Just Eat Holding Limited for 1.5 billion euros in cash.

It was in August that Prosus group entered into an agreement to acquire the remaining stake. Closing of the transaction was subject to approval by the Just Eat Takeway.com shareholders .

The deal prise also includes a contingent consideration of up to a maximum of 300 million in cash .

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Elon Musk's brain implant firm Neuralink said it has received approval from the U.S. Food and Drug Administration to conduct first-in-human clinical trials. In a tweet, Neuralink said, "We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study! T.W. Garner Food Co. is recalling 50,688 bottles of 12 oz. Texas Pete Buffalo Wing Sauce citing undeclared soy, the U.S. Food and Drug Administration said. The agency noted that some of the bottles may contain Texas Pete Extra Mild Wing Sauce which contains soy. The recall involves Texas Pete Buffalo Wing Sauce with best used by 120623T 065239 UPC 0 75500 10011 6. The U.S. Food and Drug Administration approved Pfizer Inc's COVID-19 oral antiviral pill Paxlovid for the treatment of mild-to-moderate COVID-19 in adults. Paxlovid is the first oral treatment, and the fourth drug, approved by the agency to treat COVID-19 in adults. Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) has been approved to treat adults who are at high...
Follow RTT